CTLA-4 in ACs was higher than in HDs or ACH or HCC patients (p < 0.05) and CTLA-4 in Cir patients was higher than in ACH patients (p < 0.05; Fig. 2b, c). Here, CTLA4 is linked to hepatocellular carcinoma.